Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pilot Study Evaluating Stress Response and Immune Function in Mechanically Ventilated Patients With Alcohol Use Disorders Treated With Propofol or Midazolam

This study has suspended participant recruitment.
Information provided by:
Virginia Commonwealth University Identifier:
First received: March 26, 2009
Last updated: November 10, 2010
Last verified: September 2010

The aim of this study is to evaluate the effects of the sedatives propofol and midazolam on stress response and immune function in critically ill patients with alcohol use disorders who are undergoing mechanical ventilation.

Condition Intervention Phase
Mechanical Ventilation
Drug: Propofol
Drug: Midazolam
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Randomized Clinical Trial Comparing Propofol and Midazolam in Mechanically Ventilated Critically Ill Patients With Alcohol Use Disorders: An Open Label Pilot Study

Resource links provided by NLM:

Further study details as provided by Virginia Commonwealth University:

Primary Outcome Measures:
  • Stress response and immune function. [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 10
Study Start Date: March 2009
Estimated Study Completion Date: July 2012
Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Propofol
Patients to be sedated for up to 72 hours with study drug propofol
Drug: Propofol
Patients to be sedated for up to 72 hours with study drug propofol
Experimental: Midazolam
Patients to be sedated for up to 72 hours with study drug midazolam
Drug: Midazolam
Patients to be sedated for up to 72 hours with study drug midazolam


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosis of alcohol use disorders
  • Need for invasive mechanical ventilation
  • Need for continuous intravenous infusion of sedative(s)

Exclusion Criteria:

  • Age < 18 years
  • Pregnant women
  • Prisoners
  • Receiving propofol prior to randomization
  • Patient experiencing active alcohol withdrawal
  • Immunosuppression
  • Shock
  • Attending physician does not feel patient is candidate to receive either propofol or midazolam
  • Patient has contraindication(s) to receiving either propofol or midazolam
  • Inability to enroll patient within 96 hours after initiation of mechanical ventilation
  • Transfer from another intensive care unit
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00871039

United States, Virginia
Virginia Commonwealth University Medical Center
Richmond, Virginia, United States, 23298
Virginia Commonwealth University Medical Center (formerly known as Medical College of Virginia)
Richmond, Virginia, United States, 23298
Sponsors and Collaborators
Virginia Commonwealth University
Principal Investigator: Marjolein de Wit, M.D. Virginia Commonwealth University
  More Information

No publications provided

Responsible Party: Marjolein de Wit, MD, MS, Assistant Professor of Medicine, Virginia Commonwealth University Identifier: NCT00871039     History of Changes
Other Study ID Numbers: VCU IRB HM12035
Study First Received: March 26, 2009
Last Updated: November 10, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Virginia Commonwealth University:
Mechanical ventilation

Additional relevant MeSH terms:
Alcohol-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Substance-Related Disorders
Adjuvants, Anesthesia
Anesthetics, General
Anesthetics, Intravenous
Anti-Anxiety Agents
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Modulators
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents processed this record on November 25, 2014